Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation

Although incidence of invasive meningococcal disease (IMD) in the Russian Federation is low, children younger 15 years of age are significantly affected. Serogroups A, B, and C are frequently implicated. The quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) is approved in Ru...

Full description

Bibliographic Details
Main Authors: I. Ya. Izvekova, L. S. Namazova-Baranova, A. V. Gogolev, L. V. Dubova, V. V. Romanenko, E. V. Zinnatova, G. P. Martynova, Y. Thollot, A. Paye, A. V. Goldstein
Format: Article
Language:Russian
Published: Numikom LLC 2019-01-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
менингококковая конъюгированная вакцина
menacwy-d
вакцина
безопасность
реактогенность
дети
подростки
взрослые
российская федерация
Online Access:https://www.epidemvac.ru/jour/article/view/606

Internet

https://www.epidemvac.ru/jour/article/view/606

Similar Items